LoginRegister
    Novartis abandons effort for U.S. approval of biosimilar rituximabNovartis abandons effort for U.S. approval of biosimilar rituximab
    Zydus Cadila gets USFDA Approval for Vardenafil Hydrochloride TabletsZydus Cadila gets USFDA Approval for Vardenafil Hydrochloride Tablets
    CCI approves IHH acquisition of Fortis Healthcare, Fortis Malar HospitalCCI approves IHH acquisition of Fortis Healthcare, Fortis Malar Hospital
    Strides Pharma Science to get Rs 147 Crore funding for consumer healthcare businessStrides Pharma Science to get Rs 147 Crore funding for consumer healthcare business
    Glenmark launches hair loss treatment Nourkrin in RussiaGlenmark launches hair loss treatment Nourkrin in Russia
    Breaking: Madras HC STAY blocks online sale of medicinesBreaking: Madras HC STAY blocks online sale of medicines
    Aurobindo Pharma Issues Voluntary Recall of Irbesartan Drug: FDAAurobindo Pharma Issues Voluntary Recall of Irbesartan Drug: FDA
    FDC gets 8 observation from USFDA for Waluj plantFDC gets 8 observation from USFDA for Waluj plant
    Dr Reddys Labs launches Atomoxetine Capsules in US MarketDr Reddy's Labs launches Atomoxetine Capsules in US Market
    Takeda hikes annual profit forecast by a third after second-quarter profit jumpTakeda hikes annual profit forecast by a third after second-quarter profit jump
    Merck India Charitable Trust Scholarship program, launched in BengaluruMerck India Charitable Trust Scholarship program, launched in Bengaluru
    Zydus Hospital acquires Columbia Asia Hospital in AhmadabadZydus Hospital acquires Columbia Asia Hospital in Ahmadabad
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X